Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy

NCT03337100 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03337100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03337100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2017
Completion date
September 30, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overdose, risk behavior